Using Patient Variables in CML to Guide Treatment

Video

This video highlights patient variables, including kidney function or history of diabetes, that can help guide treatment in chronic myeloid leukemia.

In this video, Ruediger Hehlmann, MD, of the University of Heidelberg in Germany, discusses patient variables-including kidney function or history of diabetes-that can help guide treatment in chronic myeloid leukemia (CML), and reviews the need for molecular monitoring for disease relapse.

Hehlmann spoke on this topic during an education session at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Related Videos
John Molina, MD, MEd, an expert on chronic myeloid leukemia
Charles A. Schiffer, MD, an expert on chronic myeloid leukemia
Charles A. Schiffer, MD, an expert on chronic myeloid leukemia
Moaath Mustafa Ali, MD, MPH, an expert on chronic myeloid leukemia
Moaath Mustafa Ali, MD, MPH, an expert on chronic myeloid leukemia
Resolving disparities within the blood cancer space is a matter of “access to excellent healthcare,” according to Usama Gergis, MD, MBA.
Jay Yang, MD, an expert on chronic myeloid leukemia, presenting clinical trial data
Discrepancies in patients with blood cancer who are eligible for but do not undergo hematopoietic stem cell transplant have been observed not only for Black patients, but Hispanic, Asian, and White patients as well, according to Usama Gergis, MD, MBA.
Related Content
T-cell Replete Cord Transplants Give Superior Outcomes in High-risk and Relapsed/refractory Pediatric Myeloid Malignancy

T-cell Replete Cord Transplants Give Superior Outcomes in High-risk and Relapsed/refractory Pediatric Myeloid Malignancy

November 22nd 2023
Article

A recent study published in Nucleus discussed the utility of T-cell replete cord blood transplant in patients with high-risk pediatric acute myeloid leukemia and myelodysplastic syndrome.

Oncology Peer Review On-The-Go: Minority Treatment Disparities and Clinical Trial Enrollment

Oncology Peer Review On-The-Go: Minority Treatment Disparities and Clinical Trial Enrollment

July 6th 2020
Podcast

The first episode of CancerNetwork's podcast Oncology Peer Review On-The-Go explores disparities in cancer care treatment among minorities and the significance of a representative sample in clinical trials.

Treatment Updates and Key Highlights in Multiple Myeloma and CML

Treatment Updates and Key Highlights in Multiple Myeloma and CML

November 13th 2023
Article

Karmanos Cancer Institute and Cleveland Clinic gave presentations regarding treatment of multiple myeloma and chronic myeloid leukemia in the latest Face Off.

Stem Cell Transplant Approaches for Patients With Blood Cancers

Stem Cell Transplant Approaches for Patients With Blood Cancers

March 13th 2019
Podcast

Dr. Scadden discusses which blood cancer patients are eligible for stem cell transplantation, as well as the latest advances in the field.

Notch Signaling Drives Intestinal Graft-versus-host Disease in Mice and Nonhuman Primates

Notch Signaling Drives Intestinal Graft-versus-host Disease in Mice and Nonhuman Primates

October 25th 2023
Article

Notch signaling acute gastrointestinal graft-vs-host disease was determined in a study analyzing mice and nonhuman primates.

Mayo Clinic and UT Southwestern “Face Off” Over Multiple Myeloma and CML

Mayo Clinic and UT Southwestern “Face Off” Over Multiple Myeloma and CML

October 20th 2023
Article

UT Southwestern and Mayo Clinic debated over current treatment options in chronic myeloid leukemia and multiple myeloma.